| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 66,572 | 51,189 | 50,065 | 66,045 | | Cost of Revenue | 41,857 | 33,471 | 29,972 | 41,234 | | | Gross Profit | 24,716 | 17,718 | 20,092 | 24,811 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 18,577 | 18,119 | 19,946 | 21,598 | | Non Recurring |
-
|
-
|
-
| 4,863 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,139 | (402) | 146 | (1,649) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 224 | 158 | (125) | (58) | | Earnings Before Interest And Taxes | 6,363 | (243) | 22 | (1,707) | | Interest Expense | 1,955 | 1,936 | 1,774 | 2,217 | | Income Before Tax | 4,408 | (2,180) | (1,752) | (3,925) | | Income Tax Expense | 1,627 | (785) | (631) | (1,684) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,781 | (1,395) | (1,121) | (2,241) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,781 | (1,395) | (1,121) | (2,241) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,781 | ($1,395) | ($1,121) | ($2,241) |
|
0.22% Nasdaq 
0.05 (0.63%) 
Income Statement
